Comments on: Endo Pharmaceuticals Announces That FDA Eliminates Need for Advisory Committee Meeting to Discuss New Formulation of Long-Acting Oxymorphone

Comments on: Endo Pharmaceuticals Announces That FDA Eliminates Need for Advisory Committee Meeting to Discuss New Formulation of Long-Acting Oxymorphone https://www.worldpharmatoday.com/press-releases/endo-pharmaceuticals-announces-that-fda-eliminates-need-for-advisory-committee-meeting-to-discuss-new-formulation-of-long-acting-oxymorphone/ Magazine for the C-level Pharma Executives Sun, 07 Nov 2010 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4